A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life.
chronic fatigue syndrome (CFS)
health-related quality of life (HRQoL)
myalgic encephalomyelitis (ME)
nutrition
nutritional intake
supplements
Journal
Food & nutrition research
ISSN: 1654-661X
Titre abrégé: Food Nutr Res
Pays: Sweden
ID NLM: 101488795
Informations de publication
Date de publication:
2021
2021
Historique:
received:
19
11
2020
revised:
01
04
2021
accepted:
02
04
2021
entrez:
15
7
2021
pubmed:
16
7
2021
medline:
16
7
2021
Statut:
epublish
Résumé
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem illness without a currently recognized pharmacological treatment. Dietary supplementation and modification have been posited as potential management strategies; however, their efficacy is controversial. This study aimed to assess the nutritional intake and supplement use of Australian ME/CFS patients and the perceived effect on health-related quality of life (HRQoL) for the first time in an Australian patient population. Between February 2019 and January 2020, ME/CFS patients across Australia volunteered in this cross-sectional study in response to online advertisements. Eligible respondents were invited to complete three online self-administered questionnaires investigating their supplement use, nutritional intake, and HRQoL. The study participants' supplement use and nutritional intake were summarized and compared with the population data returned from the Australian Health Survey (2011-2012). Multiple linear regression analysis was also performed to determine the effect of participants' supplement use and nutrient intake on HRQoL. Twenty-four eligible ME/CFS patients (54.2% meeting the International Consensus Criteria, 79.2% female, mean age = 43.4 ± 10.5 years) completed the online questionnaires. Supplement use was highly prevalent among the study sample (87.5%) and considerably more common when compared with population data (31.9%). Daily total fats and caffeine intakes were significantly higher among ME/CFS patients when compared with the Australian population ( The daily diet and supplement use of ME/CFS patients appear to vary considerably from those of the general Australian population. Although the role of nutritional intake and supplement use on ME/CFS patients' HRQoL remains unclear, dietary changes and the use of supplements appear to be of value to ME/CFS patients.
Sections du résumé
BACKGROUND
BACKGROUND
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem illness without a currently recognized pharmacological treatment. Dietary supplementation and modification have been posited as potential management strategies; however, their efficacy is controversial.
OBJECTIVE
OBJECTIVE
This study aimed to assess the nutritional intake and supplement use of Australian ME/CFS patients and the perceived effect on health-related quality of life (HRQoL) for the first time in an Australian patient population.
DESIGN
METHODS
Between February 2019 and January 2020, ME/CFS patients across Australia volunteered in this cross-sectional study in response to online advertisements. Eligible respondents were invited to complete three online self-administered questionnaires investigating their supplement use, nutritional intake, and HRQoL. The study participants' supplement use and nutritional intake were summarized and compared with the population data returned from the Australian Health Survey (2011-2012). Multiple linear regression analysis was also performed to determine the effect of participants' supplement use and nutrient intake on HRQoL.
RESULTS
RESULTS
Twenty-four eligible ME/CFS patients (54.2% meeting the International Consensus Criteria, 79.2% female, mean age = 43.4 ± 10.5 years) completed the online questionnaires. Supplement use was highly prevalent among the study sample (87.5%) and considerably more common when compared with population data (31.9%). Daily total fats and caffeine intakes were significantly higher among ME/CFS patients when compared with the Australian population (
CONCLUSIONS
CONCLUSIONS
The daily diet and supplement use of ME/CFS patients appear to vary considerably from those of the general Australian population. Although the role of nutritional intake and supplement use on ME/CFS patients' HRQoL remains unclear, dietary changes and the use of supplements appear to be of value to ME/CFS patients.
Identifiants
pubmed: 34262415
doi: 10.29219/fnr.v65.5730
pii: 5730
pmc: PMC8254462
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
© 2021 Breanna Weigel et al.
Déclaration de conflit d'intérêts
The authors declare that there are no potential competing interests (financial or non-financial) relevant to this study. This study was funded by the Mason Foundation, The Stafford Fox Medical Research Foundation, Mc-Cusker Charitable Foundation, Mr Douglas Stutt, Alison Hunter Memorial Foundation, Buxton Foundation, Blake Beckett Trust, Henty Donation, and the Change for ME Charity.
Références
Integr Physiol Behav Sci. 1998 Jan-Mar;33(1):61-71
pubmed: 9594356
BMC Public Health. 2011 May 27;11:402
pubmed: 21619607
Adv Nutr. 2017 May 15;8(3):463-472
pubmed: 28507011
Med Sci Monit. 2014 Jan 14;20:47-53
pubmed: 24419360
Diagnostics (Basel). 2019 Jul 20;9(3):
pubmed: 31330791
Psychosomatics. 2017 Sep - Oct;58(5):533-543
pubmed: 28596045
Ann Med. 2019;51(sup1):2-14
pubmed: 30735059
Ann Epidemiol. 2013 Jun;23(6):371-6
pubmed: 23683713
BMC Public Health. 2019 Jun 28;19(1):840
pubmed: 31253111
Altern Med Rev. 2000 Apr;5(2):93-108
pubmed: 10767667
Biofactors. 2016 Jul 8;42(4):431-40
pubmed: 27125909
Med Hypotheses. 2015 Dec;85(6):765-73
pubmed: 26604026
J Transl Med. 2020 Feb 24;18(1):100
pubmed: 32093722
BMJ Open. 2019 Mar 7;9(3):e023955
pubmed: 30850404
J Hum Nutr Diet. 2009 Jun;22(3):226-31
pubmed: 19226353
Neuro Endocrinol Lett. 2009;30(4):470-6
pubmed: 20010505
Br J Pharmacol. 2017 Mar;174(5):345-369
pubmed: 28052319
Altern Med Rev. 2001 Oct;6(5):450-9
pubmed: 11703165
Korean J Anesthesiol. 2017 Apr;70(2):144-156
pubmed: 28367284
J Altern Complement Med. 2010 Mar;16(3):235-49
pubmed: 20192908
Biomed Pharmacother. 2019 Jan;109:1000-1007
pubmed: 30551349
Public Health Nutr. 2016 Sep;19(13):2357-68
pubmed: 27075344
Eval Health Prof. 2012 Sep;35(3):280-304
pubmed: 22158691
Nutr Hosp. 2012 Mar-Apr;27(2):659-62
pubmed: 22732998
Reumatol Clin. 2016 Mar-Apr;12(2):72-7
pubmed: 26190206
Health Qual Life Outcomes. 2009 Jul 20;7:67
pubmed: 19619330
Qual Life Res. 2020 Jun;29(6):1521-1531
pubmed: 31970624
Ann Intern Med. 1994 Dec 15;121(12):953-9
pubmed: 7978722
Front Pediatr. 2017 Jun 19;5:121
pubmed: 28674681
Arthritis Care Res (Hoboken). 2017 Dec;69(12):1920-1925
pubmed: 28217907
Health Qual Life Outcomes. 2003 Dec 02;1:74
pubmed: 14651754
Med Hypotheses. 2015 Nov;85(5):690-3
pubmed: 26315446
J Hum Nutr Diet. 2017 Jun;30(3):247-259
pubmed: 28111818
PLoS One. 2015 Jul 06;10(7):e0132421
pubmed: 26147503
Arch Fam Med. 1993 Feb;2(2):181-6
pubmed: 8275187
PLoS One. 2017 Apr 28;12(4):e0176631
pubmed: 28453534
Front Pediatr. 2019 Feb 05;7:12
pubmed: 30805319
Clin Epidemiol. 2016 May 17;8:97-107
pubmed: 27279748
Metab Brain Dis. 2019 Apr;34(2):385-415
pubmed: 30758706
J Intern Med. 2011 Oct;270(4):327-38
pubmed: 21777306
QJM. 2002 Oct;95(10):677-83
pubmed: 12324640
Asia Pac J Clin Nutr. 1994 Mar;3(1):19-31
pubmed: 24351203
Scand J Pain. 2019 Jan 28;19(1):61-72
pubmed: 30325738
Syst Rev. 2019 Nov 14;8(1):279
pubmed: 31727160
J Transl Med. 2018 Oct 1;16(1):268
pubmed: 30285773
Aust Fam Physician. 2011 Nov;40(11):907-12
pubmed: 22059223
J Transl Med. 2020 Jul 29;18(1):289
pubmed: 32727489
J Transl Med. 2021 Feb 17;19(1):81
pubmed: 33596913
Nutr Metab Cardiovasc Dis. 2015 Mar;25(3):287-94
pubmed: 25455721
Clin Nutr. 2016 Aug;35(4):826-34
pubmed: 26212172
Nutr J. 2010 Nov 22;9:55
pubmed: 21092175
BMC Psychiatry. 2020 Jun 18;20(1):315
pubmed: 32552785
J Intern Med. 2012 Jul;272(1):74-84
pubmed: 22112145
Autoimmun Rev. 2018 Jun;17(6):601-609
pubmed: 29635081
BMJ Open. 2014 Feb 07;4(2):e003973
pubmed: 24508851
J Clin Pathol. 2007 Feb;60(2):122-4
pubmed: 16935966